Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mangoceuticals Inc (MGRX)

Mangoceuticals Inc (MGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mangoceuticals Inc 15110 DALLAS PKWY SUITE 600 DALLAS TX 75248 USA

www.mangoceuticals.com P: 214-242-9619

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Mangoceuticals Inc. is involved in developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction drug branded `Mango`. Mangoceuticals Inc. is based in DALLAS, TX.

Key Statistics

Overview:

Market Capitalization, $K 9,912
Enterprise Value, $K 9,852
Shares Outstanding, K 13,907
Annual Sales, $ 620 K
Annual Net Income, $ -8,710 K
Last Quarter Sales, $ 80 K
Last Quarter Net Income, $ -7,620 K
EBIT, $ -19,340 K
EBITDA, $ -18,610 K
60-Month Beta 2.56
% of Insider Shareholders 16.00%
% of Institutional Shareholders 56.72%
Float, K 11,682
% Float 84.00%
Short Interest 537
Short Float 3.86%
Short Volume Ratio 0.45

Growth:

1-Year Return -74.72%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.69 on 11/14/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -3.56
EPS Growth vs. Prev Qtr -21.05%
EPS Growth vs. Prev Year 30.30%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 10/16/24

MGRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -114.63%
Return-on-Assets % -106.42%
Profit Margin % -1,404.84%
Debt/Equity 0.00
Price/Sales 17.38
Price/Cash Flow N/A
Price/Book 0.68
Book Value/Share 1.13
Interest Coverage -870.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar